Umbilical cord blood transplantation: current practice and future innovations

被引：63

作者：

Barker, JN

Wagner, JE

机构：

[1] Univ Minnesota, Sch Med, Dept Med, Blood & Marrow Transplant Program, Minneapolis, MN 55455 USA

[2] Univ Minnesota, Sch Med, Dept Pediat, Blood & Marrow Transplant Program, Minneapolis, MN 55455 USA

来源：

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2003年 / 48卷 / 01期

关键词：

hematopoietic stem cells; umbilical cord blood; allogeneic transplantation; acute leukemia;

D O I：

10.1016/S1040-8428(03)00092-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

As a source of hematopoietic stem cells (HSCs), umbilical cord blood (UCB) has the advantages of speed of availability, tolerance of 1-2 antigen HLA mismatch, and a low incidence of severe GVHD. Thus, UCB represents a highly convenient HSC source that may significantly extend the HSC donor pool. UCB transplantation (UCBT) has become a standard practice in the treatment of pediatric malignancies. Now, UCBT is being investigated in adults using both conventional and non-myeloablative preparative regimens. As graft cell dose is the major factor determining hematopoietic recovery and survival in URD UCBT, methods to increase cell dose such as multiple-unit transplant and ex vivo expansion are being pursued. This review outlines the current status of UCBT with emphasis on current and future innovations. (C) 2003 Elsevier Ireland Ltd. All rights reserved.

引用

页码：35 / 43

页数：9

共 47 条

[31] Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen [J].

Rizzieri, DA ;

Long, GD ;

Vredenburgh, JJ ;

Gasparetto, C ;

Morris, A ;

Stenzel, TT ;

Davis, P ;

Chao, NJ .

BLOOD, 2001, 98 (12) :3486-3488

[32] Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-Identical sibling. [J].

Rocha, V ;

Wagner, JE ;

Sobocinski, KA ;

Klein, JP ;

Zhang, MJ ;

Horowitz, MM ;

Gluckman, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1846-1854

[33] Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia [J].

Rocha, V ;

Cornish, J ;

Sievers, EL ;

Filipovich, A ;

Locatelli, F ;

Peters, C ;

Remberger, M ;

Michel, G ;

Arcese, W ;

Dallorso, S ;

Tiedemann, K ;

Busca, A ;

Chan, KW ;

Kato, S ;

Ortega, J ;

Vowels, M ;

Zander, A ;

Souillet, G ;

Oakill, A ;

Woolfrey, A ;

Pay, AL ;

Green, A ;

Garnier, F ;

Ionescu, I ;

Wernet, P ;

Sirchia, G ;

Rubinstein, P ;

Chevret, S ;

Gluckman, E .

BLOOD, 2001, 97 (10) :2962-2971

[34]

Roncarolo M G, 1996, J Hematother, V5, P157, DOI 10.1089/scd.1.1996.5.157

[35] Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results [J].

Rubinstein, P ;

Stevens, CE .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2000, 13 (04) :565-584

[36] Outcomes among 562 recipients of placental-blood transplants from unrelated donors [J].

Rubinstein, P ;

Carrier, C ;

Scaradavou, A ;

Kurtzberg, J ;

Adamson, J ;

Migliaccio, AR ;

Berkowitz, RL ;

Cabbad, M ;

Dobrila, NL ;

Taylor, PE ;

Rosenfield, RE ;

Stevens, CE .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1565-1577

[37] Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: The effect of leukemic burden, donor HLA-matching, and marrow cell dose [J].

Sierra, J ;

Storer, B ;

Hansen, JA ;

Bjerke, JW ;

Martin, PJ ;

Petersdorf, EW ;

Appelbaum, FR ;

Bryant, E ;

Chauncey, TR ;

Sale, G ;

Sanders, JE ;

Storb, R ;

Sullivan, KM ;

Anasetti, C .

BLOOD, 1997, 89 (11) :4226-4235

[38] Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience [J].

Sierra, J ;

Storer, B ;

Hansen, JA ;

Martin, PJ ;

Petersdorf, EW ;

Woolfrey, A ;

Matthews, D ;

Sanders, JE ;

Storb, R ;

Appelbaum, FR ;

Anasetti, C .

BONE MARROW TRANSPLANTATION, 2000, 26 (04) :397-404

[39]

Sorg RV, 1998, BONE MARROW TRANSPL, V22, pS52

[40] A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation [J].

Talvensarri, K ;

Clave, E ;

Douay, C ;

Rabian, C ;

Garderet, L ;

Busson, M ;

Garnier, F ;

Douek, D ;

Gluckman, E ;

Charron, D ;

Toubert, A .

BLOOD, 2002, 99 (04) :1458-1464

← 1 2 3 4 5 →